57 related articles for article (PubMed ID: 1601393)
1. Effect of the prostaglandin E1 analog enisoprost on glucose and lipid metabolism in patients with type II diabetes mellitus.
Kasim SE; Moran M; Khilnani S; West MA; Jen KL
Horm Metab Res; 1992 Apr; 24(4):176-80. PubMed ID: 1601393
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone-induced changes in lipid metabolism.
Kasim SE; Bagchi N; Brown TR; Khilnani S; Jackson K; Steinman RT; Lehmann MH
Horm Metab Res; 1990 Jul; 22(7):385-8. PubMed ID: 2401448
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
4. Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes.
Baynes C; Rains SG; Wadsworth J; Wilson GA; Richmond W; Elkeles RS
Diabetes Res; 1991 Feb; 16(2):49-53. PubMed ID: 1817805
[TBL] [Abstract][Full Text] [Related]
5. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Lam KS; Chan MK; Yeung RT
Q J Med; 1986 May; 59(229):513-21. PubMed ID: 3763814
[TBL] [Abstract][Full Text] [Related]
7. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
8. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
9. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
Garg ML; Blake RJ; Clayton E; Munro IA; Macdonald-Wicks L; Singh H; Moughan PJ
Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
11. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
[TBL] [Abstract][Full Text] [Related]
12. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
[TBL] [Abstract][Full Text] [Related]
13. [Maternal serum lipid at 36-42 weeks' gestation and their relationship to newborn weight in pregnant women with gestational diabetes mellitus and type 1 and type 2 diabetes mellitus].
He B; Li SQ; Wang W; Han P
Zhonghua Fu Chan Ke Za Zhi; 2004 Oct; 39(10):675-7. PubMed ID: 16144564
[TBL] [Abstract][Full Text] [Related]
14. Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
Kasim SE; Darga LL; Holden JH; Khilnani S; Patton S; Jen KL; Lucas CP
Int J Obes; 1991 Dec; 15(12):833-40. PubMed ID: 1794925
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lipase and the clearing reaction: studies in euthyroid and hypothyroid subjects.
Valdemarsson S; Nilsson-Ehle P
Horm Metab Res; 1987 Jan; 19(1):28-30. PubMed ID: 3557280
[TBL] [Abstract][Full Text] [Related]
16. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients.
Kasim SE; Stern B; Khilnani S; McLin P; Baciorowski S; Jen KL
J Clin Endocrinol Metab; 1988 Jul; 67(1):1-5. PubMed ID: 3379125
[TBL] [Abstract][Full Text] [Related]
17. The effects of gender and type of diabetes on HDL-cholesterol.
Merrin PK; Baynes C; Henderson A; Richmond B; Elkeles R
Diabete Metab; 1994; 20(1):20-4. PubMed ID: 8056130
[TBL] [Abstract][Full Text] [Related]
18. Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus.
Kasim SE; Tseng K; Jen KL; Khilnani S
J Clin Endocrinol Metab; 1987 Jul; 65(1):183-7. PubMed ID: 3584394
[TBL] [Abstract][Full Text] [Related]
19. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.
Knudsen P; Eriksson J; Lahdenperä S; Kahri J; Groop L; Taskinen MR
Diabetologia; 1995 Mar; 38(3):344-50. PubMed ID: 7758882
[TBL] [Abstract][Full Text] [Related]
20. Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Laakso M; Sarlund H; Ehnholm C; Voutilainen E; Aro A; Pyörälä K
Diabetologia; 1987 Sep; 30(9):703-6. PubMed ID: 3428502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
